Tasipimidine
Tasipimidine is an orally active and selective α2A-adrenoceptor agonist with a pEC50 of 7.57 for human α2A-adrenoceptors and an EC50 of 5.7 nM for rat α2-adrenoceptor. Tasipimidine can be utilized in research related to situational anxiety and fear[1][2].
Product Specifications
CAS Number
1465908-70-6
UNSPSC
12352005
Target
Adrenergic Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/tasipimidine.html
Smiles
COC1=C2CCOC(C3=NCCN3)C2=CC=C1
Molecular Formula
C13H16N2O2
Molecular Weight
232.28
References & Citations
[1]Lehtimäki J, et al. Tasipimidine-the pharmacological profile of a novel orally active selective α2A-adrenoceptor agonist. Eur J Pharmacol. 2022 May 15;923:174949.|[2]Korpivaara M, et al. Tasipimidine, a novel orally administered alpha-2 adrenoceptor agonist, alleviates canine acute anxiety associated with owner departure—A pilot study. Journal of Veterinary Behavior, 2022, 58: 54-61.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
α adrenergic receptor
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog